Brief: Natco Pharma Says Co Files Generic Erdafitinib Tablets In Usa
26/07/2023 08:44
July 26 (Reuters) - Natco Pharma Ltd NATP.NS :
* NATCO FILES GENERIC ERDAFITINIB TABLETS IN USA
Source text for Eikon: ID:nBSE78ww9Z
Further company coverage: NATP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees